Error loading player: No playable sources found
Session III: Innovative Bioassay Formats
Date
April 22, 2021
This product is not available for individual purchase, but it is available as part of the following products:
Session Chairs
BfArM-Federal Institute for Drugs and Medical Devices
Novartis Pharma AG
F. Hoffmann - La Roche Ltd.
Session Speakers
Genentech, a Member of the Roche Group
Novartis
F. Hoffmann-La Roche AG
Boehringer Ingelheim Pharma GmbH & Co. KG
Related Products
Keynote Presentation - Bioassay Evolution - Where Are We Now?
Bioassays have been an area of contention and discussion for decades. The understanding of the relationship between potency, biological activity and mechanism of action always seems to lead to dialogue with regulators, even today…
Enhancing the Speed of Vaccine Development by Utilizing Fully Automated High throughput Cell Potency Assays
High-throughput analytical assays are one of the key enabling strategies which are needed to support vaccine development…
